NexMR aims to deliver fully characterized hits to support drug discovery pipelines.
Thanks to our proprietary technology using sensitivity-enhanced NMR we can screen libraries of thousands of molecules within days. We are also able to characterize the hits without idle time, as our technology encompasses affinity and structure determination.
Contrary to state-of-the-art methods (X-ray crystallography, surface plasmon resonance), we only require minimal assay development, allowing us to screen challenging targets which were not addressed so far.
The sample conditions used in NMR are milder and closer to physiological conditions than for other techniques, therefore facilitating the transition to further development.
Thanks to our proprietary technology using sensitivity-enhanced NMR we can screen libraries of thousands of molecules within days. We are also able to characterize the hits without idle time, as our technology encompasses affinity and structure determination.
Contrary to state-of-the-art methods (X-ray crystallography, surface plasmon resonance), we only require minimal assay development, allowing us to screen challenging targets which were not addressed so far.
The sample conditions used in NMR are milder and closer to physiological conditions than for other techniques, therefore facilitating the transition to further development.
Location: Switzerland, Zurich
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Mentions in press and media 6
| Date | Title | Description |
| 11.11.2024 | Strong startup delegation at Medica 2024 | With over 6,100 international exhibitors and a total of 83,000 trade visitors, Medica is the world's leading trade fair for the medical technology industry. Slated to take place from 11-14 November in Düsseldorf, the trade fair brings toge... |
| 06.09.2024 | Kickfund invests at full throttle | Kickfund Ventures Fund I is a new investment fund dedicated to enhancing Switzerland's innovation ecosystem by supporting deep tech startups have successfully participated in the Venture Kick competition. With an initial closing of CHF 70 ... |
| 25.01.2024 | ZKB Pionierpreis Technopark shortlists 11 startups | The Pionierpreis is an initiative by Zürcher Kantonalbank and Technopark Zürich and has been running for more than two decades, promoting outstanding technology startups. The selection of the first startups for the 2024 competition brings ... |
| 23.12.2022 | NexMR secures funds to accelerate drug discovery | |
| 15.06.2022 | CHF 40,000 for a NMR-based fragment screening platform and miniature sensors in the EVD | NexMR: NMR-based fragment screening made easy Fragment-based drug design(FBDD) successfully brought over forty drugs to the clinics and four to the market. However, state-of-the-art techniques often fail to address the most challenging targ... |
| 30.03.2022 | Startups developing microwave passive devices, a NMR-based fragment screening platform, a new way to play videogames, miniature sensors in the EVD, an handwriting iPad app for children, and radiation ... | MinWave Technologies: Microwave passive devices 10x smaller, 10x lighter Passive RF devices are parts of communication systems that lie in between the antenna and the electronics part. They exist in any communication system, such as satelli... |